140 related articles for article (PubMed ID: 7897822)
1. Fibrinolytic activity and platelet release reaction in essential hypertension.
Keskin A; Tombuloglu M; Büyükkeçeci F
Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
[TBL] [Abstract][Full Text] [Related]
2. Platelet function and fibrinolytic activity during rest and exercise in borderline hypertensive patients.
Gleerup G; Vind J; Winther K
Eur J Clin Invest; 1995 Apr; 25(4):266-70. PubMed ID: 7601202
[TBL] [Abstract][Full Text] [Related]
3. Platelet function and fibrinolytic activity in patients with bronchial asthma.
Tutluoglu B; Gurel CB; Ozdas SB; Musellim B; Erturan S; Anakkaya AN; Kilinc G; Ulutin T
Clin Appl Thromb Hemost; 2005 Jan; 11(1):77-81. PubMed ID: 15678276
[TBL] [Abstract][Full Text] [Related]
4. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
5. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
6. [Changes of the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cerebral infarction induced by the venous occlusion].
Wakamatsu S; Banno T; Tohnai M; Oguri T
Nihon Ronen Igakkai Zasshi; 1995; 32(8-9):566-70. PubMed ID: 8531402
[TBL] [Abstract][Full Text] [Related]
7. Study of in vivo platelet activation in uncomplicated essential hypertension.
Guicheney P; Baudouin-Legros M; Meyer P
Life Sci; 1987 Feb; 40(7):615-21. PubMed ID: 2949131
[TBL] [Abstract][Full Text] [Related]
8. The impact of static work on fibrinolysis and platelet function.
Vind J; Gleerup G; Nielsen PT; Winther K
Thromb Res; 1993 Dec; 72(5):441-6. PubMed ID: 8303686
[TBL] [Abstract][Full Text] [Related]
9. Altered plasma fibrin clot properties in essential thrombocythemia.
Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
[TBL] [Abstract][Full Text] [Related]
10. Effect of infective endocarditis on blood coagulation and platelet activation and comparison of patients with to those without embolic events.
Ileri M; Alper A; Senen K; Durmaz T; Atak R; Hisar I; Yetkin E; Turhan H; Demirkan D
Am J Cardiol; 2003 Mar; 91(6):689-92. PubMed ID: 12633799
[TBL] [Abstract][Full Text] [Related]
11. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events.
Buyukasýk NS; Ileri M; Alper A; Senen K; Atak R; Hisar I; Yetkin E; Turhan H; Demirkan D
Clin Cardiol; 2004 Mar; 27(3):154-8. PubMed ID: 15049384
[TBL] [Abstract][Full Text] [Related]
12. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.
Rångemark C; Hedner JA; Carlson JT; Gleerup G; Winther K
Sleep; 1995 Apr; 18(3):188-94. PubMed ID: 7610315
[TBL] [Abstract][Full Text] [Related]
13. Effects of isradipine sustained release on platelet function and fibrinolysis in essential hypertensives with or without other risk factors.
Ranieri G; Filitti V; Andriani A; Bonfantino MV; Lamontanara G; Cavallo A; Milani M; De Cesaris R
Cardiovasc Drugs Ther; 1996 May; 10(2):119-23. PubMed ID: 8842503
[TBL] [Abstract][Full Text] [Related]
14. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
Winther K; Gleerup G; Hedner T
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
[TBL] [Abstract][Full Text] [Related]
15. Haemostatic variables in arterial hypertension.
Trifiletti A; Barbera N; Pizzoleo MA; Lasco A; Lucifora S; Leone G; Soraci S; Pedullà M; Frisina N
Haemostasis; 1995; 25(5):237-40. PubMed ID: 7489962
[TBL] [Abstract][Full Text] [Related]
16. Dynamic changes in plasma tissue plasminogen activator, plasminogen activator inhibitor-1 and beta-thromboglobulin content in ischemic stroke.
Zhuang P; Wo D; Xu ZG; Wei W; Mao HM
J Clin Neurosci; 2015 Jul; 22(7):1123-7. PubMed ID: 26002716
[TBL] [Abstract][Full Text] [Related]
17. The effects of chronic smoking on the fibrinolytic potential of plasma and platelets.
Simpson AJ; Gray RS; Moore NR; Booth NA
Br J Haematol; 1997 Apr; 97(1):208-13. PubMed ID: 9136967
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic parameters in patients with primitive venous hypertension.
Trifiletti A; Scamardi R; Pizzoleo MA; Nevoso A; Attina A; Soraci S; Bagnato L; Barbera N
Panminerva Med; 1997 Jun; 39(2):100-2. PubMed ID: 9230618
[TBL] [Abstract][Full Text] [Related]
20. Reduced in vitro clot lysis and release of more active platelet PAI-1 in polycythemia vera and essential thrombocythemia.
Pósán E; Ujj G; Kiss A; Telek B; Rák K; Udvardy M
Thromb Res; 1998 Apr; 90(2):51-6. PubMed ID: 9684757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
